Colicin Z, a structurally and functionally novel colicin type that selectively kills enteroinvasive Escherichia coli and Shigella strains
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
31366939
PubMed Central
PMC6668396
DOI
10.1038/s41598-019-47488-8
PII: 10.1038/s41598-019-47488-8
Knihovny.cz E-zdroje
- MeSH
- Escherichia coli genetika MeSH
- koliciny genetika MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- mladiství MeSH
- plazmidy genetika MeSH
- sekvence nukleotidů MeSH
- Shigella genetika MeSH
- Check Tag
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- koliciny MeSH
Colicin production in Escherichia coli (E. coli) strains represents an important trait with regard to microbial survival and competition in the complex intestinal environment. A novel colicin type, colicin Z (26.3 kDa), was described as a product of an original producer, extraintestinal E. coli B1356 strain, isolated from the anorectal abscess of a 17 years-old man. The 4,007 bp plasmid (pColZ) was completely sequenced and colicin Z activity (cza) and colicin Z immunity (czi) genes were identified. The cza and czi genes are transcribed in opposite directions and encode for 237 and 151 amino acid-long proteins, respectively. Colicin Z shows a narrow inhibitory spectrum, being active only against enteroinvasive E. coli (EIEC) and Shigella strains via CjrC receptor recognition and CjrB- and ExbB-, ExbD-mediated colicin translocation. All tested EIEC and Shigella strains isolated between the years 1958-2010 were sensitive to colicin Z. The lethal effect of colicin Z was found to be directed against cell wall peptidoglycan (PG) resulting in PG degradation, as revealed by experiments with Remazol Brilliant Blue-stained purified peptidoglycans and with MALDI-TOF MS analyses of treated PG. Colicin Z represents a new class of colicins that is structurally and functionally distinct from previously studied colicin types.
Central European Institute of Technology Masaryk University Kamenice 5 625 00 Brno Czech Republic
Department of Biosciences University of Oslo P O Box 1066 Blindern 0316 Oslo Norway
Zobrazit více v PubMed
Majeed H, Gillor O, Kerr B, Riley MA. Competitive interactions in Escherichia coli populations: the role of bacteriocins. ISME J. 2011;5:71–8. doi: 10.1038/ismej.2010.90. PubMed DOI PMC
Braun V, Pilsl H, Gross P. Colicins: structures, modes of action, transfer through membranes, and evolution. Arch. Microbiol. 1994;161:199–206. doi: 10.1007/BF00248693. PubMed DOI
Šmarda J, Šmajs D. Colicins–exocellular lethal proteins of Escherichia coli. Folia Microbiol. (Praha). 1998;43:563–582. doi: 10.1007/BF02816372. PubMed DOI
Cascales E, et al. Colicin biology. Microbiol. Mol. Biol. Rev. 2007;71:158–229. doi: 10.1128/MMBR.00036-06. PubMed DOI PMC
Duquesne S, Destoumieux-Garzón D, Peduzzi J, Rebuffat S. Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat. Prod. Rep. 2007;24:708–734. doi: 10.1039/b516237h. PubMed DOI
Timmis K. Purification and characterization of colicin D. J. Bacteriol. 1972;109:12–20. PubMed PMC
Šmajs D, Weinstock GM. Genetic organization of plasmid ColJs, encoding colicin Js activity, immunity, and release genes. J. Bacteriol. 2001;183:3949–3957. doi: 10.1128/JB.183.13.3949-3957.2001. PubMed DOI PMC
Riley MA, Gordon DM. The ecological role of bacteriocins in bacterial competition. Trends Microbiol. 1999;7:129–133. doi: 10.1016/S0966-842X(99)01459-6. PubMed DOI
Kerr B, Riley MA, Feldman MW, Bohannan BJ. Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature. 2002;418:171–174. doi: 10.1038/nature00823. PubMed DOI
Lenski RE, Riley MA. Chemical warfare from an ecological perspective. Proc. Natl. Acad. Sci. USA. 2002;99:556–558. doi: 10.1073/pnas.022641999. PubMed DOI PMC
Wassenaar TM. Insights from 100 years of research with probiotic E. coli. Eur. J. Microbiol. Immunol. (Bp). 2016;6:147–161. doi: 10.1556/1886.2016.00029. PubMed DOI PMC
Azpiroz MF, Poey ME, Laviña M. Microcins and urovirulence in Escherichia coli. Microb. Pathog. 2009;47:274–280. doi: 10.1016/j.micpath.2009.09.003. PubMed DOI
Šmajs D, et al. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiol. 2010;10:288. doi: 10.1186/1471-2180-10-288. PubMed DOI PMC
Budič M, Rijavec M, Petkovšek Z, Zgur-Bertok D. Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia. PLoS ONE. 2011;6:e28769. doi: 10.1371/journal.pone.0028769. PubMed DOI PMC
Micenková L, et al. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. BMC Microbiol. 2014;14:109. doi: 10.1186/1471-2180-14-109. PubMed DOI PMC
Micenková L, Bosák J, Vrba M, Ševčíková A, Šmajs D. Human extraintestinal pathogenic Escherichia coli strains differ in prevalence of virulence factors, phylogroups, and bacteriocin determinants. BMC Microbiol. 2016;16:218. doi: 10.1186/s12866-016-0835-z. PubMed DOI PMC
Micenková L, et al. Human Escherichia coli isolates from hemocultures: Septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions. Int. J. Med. Microbiol. 2017;307:182–189. doi: 10.1016/j.ijmm.2017.02.003. PubMed DOI
Rendueles O, Beloin C, Latour-Lambert P, Ghigo JM. A new biofilm-associated colicin with increased efficiency against biofilm bacteria. ISME J. 2014;8:1275–1288. doi: 10.1038/ismej.2013.238. PubMed DOI PMC
Chan PT, Ohmori H, Tomizawa J, Lebowitz J. Nucleotide sequence and gene organization of ColE1 DNA. J. Biol. Chem. 1985;260:8925–8935. PubMed
Gillor O, Vriezen JA, Riley MA. The role of SOS boxes in enteric bacteriocin regulation. Microbiology. 2008;154:1783–92. doi: 10.1099/mic.0.2007/016139-0. PubMed DOI PMC
Geli V, Baty D, Pattus F, Lazdunski C. Topology and function of the integral membrane protein conferring immunity to colicin A. Mol. Microbiol. 1989;3:679–87. doi: 10.1111/j.1365-2958.1989.tb00216.x. PubMed DOI
Šmajs D, Weinstock GM. The iron- and temperature-regulated cjrBC genes of Shigella and enteroinvasive Escherichia coli strains code for colicin Js uptake. J. Bacteriol. 2001;183:3958–3966. doi: 10.1128/JB.183.13.3958-3966.2001. PubMed DOI PMC
Riley MA, Wertz JE. Bacteriocins: evolution, ecology, and application. Annu Rev. Microbiol. 2002;56:117–137. doi: 10.1146/annurev.micro.56.012302.161024. PubMed DOI
Braun V, Pilsl H, Gross P. Colicins: structures, modes of action, transfer through membranes, and evolution. Arch. Microbiol. 1994;161:199–206. doi: 10.1007/BF00248693. PubMed DOI
Arnold T, Zeth K, Linke D. Structure and function of colicin S4, a colicin with a duplicated receptor-binding domain. J. Biol. Chem. 2009;284:6403–6413. doi: 10.1074/jbc.M808504200. PubMed DOI PMC
Sano Y, Kobayashi M, Kageyama M. Functional domains of S-type pyocins deduced from chimeric molecules. J. Bacteriol. 1993;175:6179–6185. doi: 10.1128/jb.175.19.6179-6185.1993. PubMed DOI PMC
Michel-Briand Y, Baysse C. The pyocins of Pseudomonas aeruginosa. Biochimie. 2002;84:499–510. doi: 10.1016/S0300-9084(02)01422-0. PubMed DOI
Bosák J, et al. Novel colicin Fy of Yersinia frederiksenii inhibits pathogenic Yersinia strains via YiuR-mediated reception, TonB import, and cell membrane pore formation. J. Bacteriol. 2012;194:1950–1959. doi: 10.1128/JB.05885-11. PubMed DOI PMC
Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Inbanathan FY, Veeraraghavan B. Accurate differentiation of Escherichia coli and Shigella serogroups: challenges and strategies. New Microbes New Infect. 2017;21:58–62. doi: 10.1016/j.nmni.2017.09.003. PubMed DOI PMC
Penfold CN, Li C, Zhang Y, Vankemmelbeke M, James R. Colicin A binds to a novel binding site of TolA in the Escherichia coli periplasm. Biochem. Soc. Trans. 2012;40:1469–1474. doi: 10.1042/BST20120239. PubMed DOI
Gordon DM, O´Brien CL. Bacteriocin diversity and the frequency of multiple production in Escherichia coli. Microbiology. 2006;152:3239–3244. doi: 10.1099/mic.0.28690-0. PubMed DOI
Bosák J, et al. Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible. PLoS One. 2013;8:e81829. doi: 10.1371/journal.pone.0081829. PubMed DOI PMC
Feldgarden M, Riley MA. High levels of colicin resistance in Escherichia coli. Evolution. 1998;52:1270–1276. doi: 10.1111/j.1558-5646.1998.tb02008.x. PubMed DOI
Nahum JR, Harding BN, Kerr B. Evolution of restraint in a structured rock–paper–scissors community. Proc. Natl. Acad. Sci. USA. 2001;108:10831–10838. doi: 10.1073/pnas.1100296108. PubMed DOI PMC
Gross P, Braun V. Colicin M is inactivated during import by its immunity protein. Mol. Gen. Genet. 1996;251:388–396. doi: 10.1007/BF02172531. PubMed DOI
Martinez MC, Lazdunski C, Pattus F. Isolation, molecular and functional properties of the C-terminal domain of colicin A. EMBO J. 1983;2:1501–1507. doi: 10.1002/j.1460-2075.1983.tb01614.x. PubMed DOI PMC
Pressler U, Braun V, Wittmann-Liebold B, Benz R. Structural and functional properties of colicin B. J. Biol. Chem. 1986;261:2654–2659. PubMed
Tettelin H, et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. USA. 2002;99:12391–12396. doi: 10.1073/pnas.182380799. PubMed DOI PMC
Lu JZ, Fujiwara T, Komatsuzawa H, Sugai M, Sakon J. Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J. Biol. Chem. 2006;281:549–558. doi: 10.1074/jbc.M509691200. PubMed DOI
Kurushima J, Hayashi I, Sugai M, Tomita H. Bacteriocin protein BacL1 of Enterococcus faecalis is a peptidoglycan D-isoglutamyl-L-lysine endopeptidase. J. Biol. Chem. 2013;288:36915–36925. doi: 10.1074/jbc.M113.506618. PubMed DOI PMC
Vollmer W, Joris B, Charlier P, Foster S. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol. Rev. 2008;32:259–286. doi: 10.1111/j.1574-6976.2007.00099.x. PubMed DOI
Šmajs D. The morphology of bacterial cells in inhibition zones produced by colicins. Scripta medica (Brno). 1995;5:171–180.
Šmajs D, Pilsl H, Braun V, Colicin U. a novel colicin produced by Shigella boydii. J. Bacteriol. 1997;179:4919–4928. doi: 10.1128/jb.179.15.4919-4928.1997. PubMed DOI PMC
Patton BS, Dickson JS, Lonergan SM, Cutler SA, Stahl CH. Inhibitory activity of colicin E1 against Listeria monocytogenes. J. Food Prot. 2007;70:1256–1262. doi: 10.4315/0362-028X-70.5.1256. PubMed DOI
Bosák J, Micenková L, Doležalová M, Šmajs D, Colicins U. and Y inhibit growth of Escherichia coli strains via recognition of conserved OmpA extracellular loop 1. Int. J. Med. Microbiol. 2016;306:486–494. doi: 10.1016/j.ijmm.2016.07.002. PubMed DOI
Guterman SK, Dann L. Excretion of enterochelin by exbA and exbB mutants of Escherichia coli. J. Bacteriol. 1973;114:1225–1230. PubMed PMC
Sun TP, Webster RE. Nucleotide sequence of a gene cluster involved in entry of E colicins and single-stranded DNA of infecting filamentous bacteriophages into Escherichia coli. J. Bacteriol. 1987;169:2667–2674. doi: 10.1128/jb.169.6.2667-2674.1987. PubMed DOI PMC
Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000;66:4555–4558. doi: 10.1128/AEM.66.10.4555-4558.2000. PubMed DOI PMC
Gómez-Moreno R, Robledo IE, Baerga-Ortiz A. Direct detection and quantification of bacterial genes associated with inflammation in DNA isolated from stool. Adv. Microbiol. 2014;4:1065–1075. doi: 10.4236/aim.2014.415117. PubMed DOI PMC
Seydlová G, et al. Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents. J. Med. Chem. 2017;60:6098–6118. doi: 10.1021/acs.jmedchem.7b00355. PubMed DOI
Zhou R, Chen S, Recsei P. A dye release assay for determination of lysostaphin activity. Anal. Biochem. 1988;171:141–144. doi: 10.1016/0003-2697(88)90134-0. PubMed DOI
Benešík M, et al. Role of SH3b binding domain in a natural deletion mutant of Kayvirus endolysin LysF1 with a broad range of lytic activity. Virus Genes. 2018;54:130–139. doi: 10.1007/s11262-017-1507-2. PubMed DOI
Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol. Biol. Evol. 2016;33:1870–1874. doi: 10.1093/molbev/msw054. PubMed DOI PMC
Gao F, Luo H, Zhang CT. DoriC 5.0: an updated database of oriC regions in both bacterial and archaeal genomes. Nucleic Acids Res. 2013;41:D90–93. doi: 10.1093/nar/gks990. PubMed DOI PMC
Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids. Res. 2015;43:W174–181. doi: 10.1093/nar/gkv342. PubMed DOI PMC
Artimo P, et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res. 2012;40:W597–W603. doi: 10.1093/nar/gks400. PubMed DOI PMC